PureTech Health plc (NASDAQ:PRTC - Get Free Report) was up 3.5% during mid-day trading on Monday . The company traded as high as $16.82 and last traded at $17.30. Approximately 650 shares traded hands during trading, a decline of 83% from the average daily volume of 3,900 shares. The stock had previously closed at $16.71.
PureTech Health Stock Performance
The business's 50-day moving average is $18.23 and its 200-day moving average is $19.65.
Institutional Trading of PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. Millennium Management LLC bought a new position in PureTech Health plc (NASDAQ:PRTC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 45,264 shares of the company's stock, valued at approximately $823,000. Millennium Management LLC owned approximately 0.19% of PureTech Health at the end of the most recent quarter. 0.04% of the stock is currently owned by hedge funds and other institutional investors.
About PureTech Health
(
Get Free Report)
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Read More
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
